The FA-functionalized Amy-F alone or prior RT abrogated proliferation, induced cell cycle arrest at pre-G1 and G2/M, and increased apoptosis as revealed by lower BCl-2 levels and higher caspase-3 levels of breast cancer cells. Here, BCL2 is linked to breast carcinoma.